Toronto, Ontario and London, United Kingdom--(Newsfile Corp. - September 6, 2024) - Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) ("Britannia" or the "Company") is pleased to announce that on September 4, 2024, the Ontario Securities Commission (the "OSC"), the Company's principal regulator, issued an order revoking the failure-to-file cease trade order that it imposed against the Company on August 2, 2024 (the "CTO"). The CTO was imposed following the Company's failure to file its audited annual financial statements and related annual management's discussion and analysis for the financial year ended March 31, 2024, and related certifications of such filings by the Company's chief executive officer and chief financial officer, (collectively, the "Annual Filings") as required by July 29, 2024.